SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-006768
Filing Date
2023-03-16
Accepted
2023-03-15 19:58:17
Documents
14
Period of Report
2023-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20230314_8k.htm   iXBRL 8-K 27203
2 EXHIBIT 99.1 ex_488965.htm EX-99.1 96170
  Complete submission text file 0001437749-23-006768.txt   267953

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20230315.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20230315_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20230315_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20230315_pre.xml EX-101.PRE 11689
8 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20230314_8k_htm.xml XML 2559
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 23736748
SIC: 2836 Biological Products, (No Diagnostic Substances)